...
search icon
bfrg-img

Bullfrog AI Holdings, Inc. Common Stock, Common Stock

BFRG

NAQ

$1.69

-$0.08

(-4.52%)

1D
Industry: Health Care Equipment & Supplies Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$15.91M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
150.96K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.64
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$1.23 L
$4.84 H
$1.69

About Bullfrog AI Holdings, Inc. Common Stock, Common Stock

Bullfrog AI Holdings, Inc., through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. The company offers bfLEAP, an analytical AI/ML platform to analyze preclinical and clinical data for biotechnology and pharmaceutical companies, and other organizations. It also develops BF-222, a novel formulation of mebendazole , which is in the first phase for the treatment of Glioblastoma; BF-223, a novel prodrug of mebendazole, which is in the preclinical stage for the treatment of Glioblastoma; BF-114, which is in the discovery phase, to treat obesity and chronic liver diseases; and Modified HSV-1, which is in the discovery phase, for the treatment of modified colorectal cancer. The company has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for use of a formulation of Mebendazole for the treatment of glioblastoma, and human cancer or neoplastic disease. It also has a partnership with the Lieber Institute for Brain Development (LIBD) to enable the discovery and development of precision treatments for CNS disorders. The company was founded in 2017 and is headquartered in Gaithersburg, Maryland. more

Industry: Health Care Equipment & SuppliesSector: Health Care

Returns

Time FrameBFRGSectorS&P500
1-Week Return-1.81%0.78%
1-Month Return-11.98%3.75%2.88%
3-Month Return6.29%-4.88%9.45%
6-Month Return-23.87%-2.96%-0.12%
1-Year Return-37.41%-6.25%11.31%
3-Year Return-74%12.43%61.11%

Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue--10.00K65.00K-[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":15.38,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue--800.005.20K1.72K[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":15.38,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":33.15,"profit":true}]
Gross Profit--9.20K59.80K-[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":15.38,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Gross Margin--92.00%92.00%-[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Operating Expenses347.19K555.36K2.46M5.43M7.24M[{"date":"2020-12-31","value":4.8,"profit":true},{"date":"2021-12-31","value":7.67,"profit":true},{"date":"2022-12-31","value":34.06,"profit":true},{"date":"2023-12-31","value":75,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income(347.19K)(555.36K)(2.46M)(5.37M)(7.24M)[{"date":"2020-12-31","value":-34719300,"profit":false},{"date":"2021-12-31","value":-55536200,"profit":false},{"date":"2022-12-31","value":-245580100,"profit":false},{"date":"2023-12-31","value":-536752400,"profit":false},{"date":"2024-12-31","value":-723638300,"profit":false}]
Total Non-Operating Income/Expense5.50K(30.48K)(693.83K)(177.70K)440.49K[{"date":"2020-12-31","value":1.25,"profit":true},{"date":"2021-12-31","value":-6.92,"profit":false},{"date":"2022-12-31","value":-157.51,"profit":false},{"date":"2023-12-31","value":-40.34,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Pre-Tax Income(341.69K)(585.84K)(2.80M)(5.36M)(7.04M)[{"date":"2020-12-31","value":-34169000,"profit":false},{"date":"2021-12-31","value":-58584000,"profit":false},{"date":"2022-12-31","value":-280248700,"profit":false},{"date":"2023-12-31","value":-535586900,"profit":false},{"date":"2024-12-31","value":-703863200,"profit":false}]
Income Taxes(194.53K)(196.16K)347.60K(5.00)(44.98K)[{"date":"2020-12-31","value":-55.96,"profit":false},{"date":"2021-12-31","value":-56.43,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":-12.94,"profit":false}]
Income After Taxes(147.16K)(389.68K)(3.15M)(5.36M)(6.99M)[{"date":"2020-12-31","value":-14716000,"profit":false},{"date":"2021-12-31","value":-38967700,"profit":false},{"date":"2022-12-31","value":-315009100,"profit":false},{"date":"2023-12-31","value":-535586400,"profit":false},{"date":"2024-12-31","value":-699364700,"profit":false}]
Income From Continuous Operations(341.69K)(585.84K)(2.80M)(4.75M)(6.99M)[{"date":"2020-12-31","value":-34169000,"profit":false},{"date":"2021-12-31","value":-58584000,"profit":false},{"date":"2022-12-31","value":-280248700,"profit":false},{"date":"2023-12-31","value":-475444100,"profit":false},{"date":"2024-12-31","value":-699364700,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(341.69K)(585.84K)(2.80M)(5.36M)(6.99M)[{"date":"2020-12-31","value":-34169000,"profit":false},{"date":"2021-12-31","value":-58584000,"profit":false},{"date":"2022-12-31","value":-280248700,"profit":false},{"date":"2023-12-31","value":-535586900,"profit":false},{"date":"2024-12-31","value":-699364700,"profit":false}]
EPS (Diluted)---(0.87)(0.87)[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":-87.29,"profit":false},{"date":"2024-12-31","value":-86.62,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

BFRG
Cash Ratio 4.53
Current Ratio 4.86

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

BFRG
ROA (LTM) -78.05%
ROE (LTM) -141.43%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

BFRG
Debt Ratio Lower is generally better. Negative is bad. 0.21
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.79

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

BFRG
Trailing PE NM
Forward PE NM
P/S (TTM) 262.62
P/B 5.13
Price/FCF NM
EV/R 205.12
EV/Ebitda NM

FAQs

What is Bullfrog AI Holdings, Inc. Common Stock share price today?

Bullfrog AI Holdings, Inc. Common Stock (BFRG) share price today is $1.69

Can Indians buy Bullfrog AI Holdings, Inc. Common Stock shares?

Yes, Indians can buy shares of Bullfrog AI Holdings, Inc. Common Stock (BFRG) on Vested. To buy Bullfrog AI Holdings, Inc. Common Stock from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in BFRG stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Bullfrog AI Holdings, Inc. Common Stock be purchased?

Yes, you can purchase fractional shares of Bullfrog AI Holdings, Inc. Common Stock (BFRG) via the Vested app. You can start investing in Bullfrog AI Holdings, Inc. Common Stock (BFRG) with a minimum investment of $1.

How to invest in Bullfrog AI Holdings, Inc. Common Stock shares from India?

You can invest in shares of Bullfrog AI Holdings, Inc. Common Stock (BFRG) via Vested in three simple steps:

  • Click on Sign Up or Invest in BFRG stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Bullfrog AI Holdings, Inc. Common Stock shares
What is Bullfrog AI Holdings, Inc. Common Stock 52-week high and low stock price?

The 52-week high price of Bullfrog AI Holdings, Inc. Common Stock (BFRG) is $4.84. The 52-week low price of Bullfrog AI Holdings, Inc. Common Stock (BFRG) is $1.23.

What is Bullfrog AI Holdings, Inc. Common Stock price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Bullfrog AI Holdings, Inc. Common Stock (BFRG) is 5.13

What is the Market Cap of Bullfrog AI Holdings, Inc. Common Stock?

The market capitalization of Bullfrog AI Holdings, Inc. Common Stock (BFRG) is $15.91M

What is Bullfrog AI Holdings, Inc. Common Stock’s stock symbol?

The stock symbol (or ticker) of Bullfrog AI Holdings, Inc. Common Stock is BFRG

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top